Pharmaceuticals

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (Brilinta) 90 mg tablets whole. Unlike other P2Y12 inhi...

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with...

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

ivabradine (Corlanor)
The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.
A study including more than 20,000 adults in China found combined use of the hypertension medication enalapril and folic acid significantly reduced the risk of...
Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled...
The Medicines Company announced that the European Commission has granted marketing authorization for two acute care products – Kengrexal (cangrelor) and...
ivabradine (Corlanor)
Ticagrelor (Brilinta) 90 mg tablets from AstraZeneca now have FDA approval to be crushed and administered in water by swallowing or via...
The Watchman left atrial appendage closure device from Boston Scientific Corp. is a catheter-delivered heart implant designed to close the...
The Xarelto Starter Pack from Janssen Pharmaceuticals Inc. was designed to help simplify the dosing for the initial 30-day treatment period...

Articles

ivabradine (Corlanor)
The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.
Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled...
Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from...
A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
2 days 18 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
4 weeks 2 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
10 weeks 2 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available